200 related articles for article (PubMed ID: 37267953)
1. Clearance of senescent macrophages ameliorates tumorigenesis in KRAS-driven lung cancer.
Haston S; Gonzalez-Gualda E; Morsli S; Ge J; Reen V; Calderwood A; Moutsopoulos I; Panousopoulos L; Deletic P; Carreno G; Guiho R; Manshaei S; Gonzalez-Meljem JM; Lim HY; Simpson DJ; Birch J; Pallikonda HA; Chandra T; Macias D; Doherty GJ; Rassl DM; Rintoul RC; Signore M; Mohorianu I; Akbar AN; Gil J; Muñoz-Espín D; Martinez-Barbera JP
Cancer Cell; 2023 Jul; 41(7):1242-1260.e6. PubMed ID: 37267953
[TBL] [Abstract][Full Text] [Related]
2. Senescent Macrophages Promote KRAS-Driven Lung Tumorigenesis.
Cancer Discov; 2023 Aug; 13(8):1758. PubMed ID: 37326376
[TBL] [Abstract][Full Text] [Related]
3. Senescent alveolar macrophages promote early-stage lung tumorigenesis.
Prieto LI; Sturmlechner I; Graves SI; Zhang C; Goplen NP; Yi ES; Sun J; Li H; Baker DJ
Cancer Cell; 2023 Jul; 41(7):1261-1275.e6. PubMed ID: 37267954
[TBL] [Abstract][Full Text] [Related]
4. Thrombospondin-1 mediates oncogenic Ras-induced senescence in premalignant lung tumors.
Baek KH; Bhang D; Zaslavsky A; Wang LC; Vachani A; Kim CF; Albelda SM; Evan GI; Ryeom S
J Clin Invest; 2013 Oct; 123(10):4375-89. PubMed ID: 24018559
[TBL] [Abstract][Full Text] [Related]
5. Twist1 suppresses senescence programs and thereby accelerates and maintains mutant Kras-induced lung tumorigenesis.
Tran PT; Shroff EH; Burns TF; Thiyagarajan S; Das ST; Zabuawala T; Chen J; Cho YJ; Luong R; Tamayo P; Salih T; Aziz K; Adam SJ; Vicent S; Nielsen CH; Withofs N; Sweet-Cordero A; Gambhir SS; Rudin CM; Felsher DW
PLoS Genet; 2012; 8(5):e1002650. PubMed ID: 22654667
[TBL] [Abstract][Full Text] [Related]
6. Miz1 promotes KRAS-driven lung tumorigenesis by repressing the protocadherin Pcdh10.
Yang J; Hou C; Wang H; Perez EA; Do-Umehara HC; Dong H; Arunagiri V; Tong F; Van Scoyk M; Cho M; Liu X; Ge X; Winn RA; Ridge KM; Wang X; Chandel NS; Liu J
Cancer Lett; 2023 Feb; 555():216025. PubMed ID: 36538983
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase Cα suppresses Kras-mediated lung tumor formation through activation of a p38 MAPK-TGFβ signaling axis.
Hill KS; Erdogan E; Khoor A; Walsh MP; Leitges M; Murray NR; Fields AP
Oncogene; 2014 Apr; 33(16):2134-44. PubMed ID: 23604119
[TBL] [Abstract][Full Text] [Related]
8. Wilms tumor 1 (WT1) regulates KRAS-driven oncogenesis and senescence in mouse and human models.
Vicent S; Chen R; Sayles LC; Lin C; Walker RG; Gillespie AK; Subramanian A; Hinkle G; Yang X; Saif S; Root DE; Huff V; Hahn WC; Sweet-Cordero EA
J Clin Invest; 2010 Nov; 120(11):3940-52. PubMed ID: 20972333
[TBL] [Abstract][Full Text] [Related]
9. NOS2 enhances KRAS-induced lung carcinogenesis, inflammation and microRNA-21 expression.
Okayama H; Saito M; Oue N; Weiss JM; Stauffer J; Takenoshita S; Wiltrout RH; Hussain SP; Harris CC
Int J Cancer; 2013 Jan; 132(1):9-18. PubMed ID: 22618808
[TBL] [Abstract][Full Text] [Related]
10. USP5-Beclin 1 axis overrides p53-dependent senescence and drives Kras-induced tumorigenicity.
Li J; Wang Y; Luo Y; Liu Y; Yi Y; Li J; Pan Y; Li W; You W; Hu Q; Zhao Z; Zhang Y; Cao Y; Zhang L; Yuan J; Xiao ZJ
Nat Commun; 2022 Dec; 13(1):7799. PubMed ID: 36528652
[TBL] [Abstract][Full Text] [Related]
11. Loss of p53 attenuates the contribution of IL-6 deletion on suppressed tumor progression and extended survival in Kras-driven murine lung cancer.
Tan X; Carretero J; Chen Z; Zhang J; Wang Y; Chen J; Li X; Ye H; Tang C; Cheng X; Hou N; Yang X; Wong KK
PLoS One; 2013; 8(11):e80885. PubMed ID: 24260500
[TBL] [Abstract][Full Text] [Related]
12. The Mir181ab1 cluster promotes KRAS-driven oncogenesis and progression in lung and pancreas.
Valencia K; Erice O; Kostyrko K; Hausmann S; Guruceaga E; Tathireddy A; Flores NM; Sayles LC; Lee AG; Fragoso R; Sun TQ; Vallejo A; Roman M; Entrialgo-Cadierno R; Migueliz I; Razquin N; Fortes P; Lecanda F; Lu J; Ponz-Sarvise M; Chen CZ; Mazur PK; Sweet-Cordero EA; Vicent S
J Clin Invest; 2020 Apr; 130(4):1879-1895. PubMed ID: 31874105
[TBL] [Abstract][Full Text] [Related]
13. Cellular Senescence in Diabetes Mellitus: Distinct Senotherapeutic Strategies for Adipose Tissue and Pancreatic β Cells.
Murakami T; Inagaki N; Kondoh H
Front Endocrinol (Lausanne); 2022; 13():869414. PubMed ID: 35432205
[TBL] [Abstract][Full Text] [Related]
14. Foxm1 transcription factor is required for the initiation of lung tumorigenesis by oncogenic Kras(G12D.).
Wang IC; Ustiyan V; Zhang Y; Cai Y; Kalin TV; Kalinichenko VV
Oncogene; 2014 Nov; 33(46):5391-6. PubMed ID: 24213573
[TBL] [Abstract][Full Text] [Related]
15. PIK3CA(H1047R) Accelerates and Enhances KRAS(G12D)-Driven Lung Tumorigenesis.
Green S; Trejo CL; McMahon M
Cancer Res; 2015 Dec; 75(24):5378-91. PubMed ID: 26567140
[TBL] [Abstract][Full Text] [Related]
16. Senescence of alveolar epithelial cells impacts initiation and chronic phases of murine fibrosing interstitial lung disease.
Yamada Z; Nishio J; Motomura K; Mizutani S; Yamada S; Mikami T; Nanki T
Front Immunol; 2022; 13():935114. PubMed ID: 36059455
[TBL] [Abstract][Full Text] [Related]
17. HDAC10 Regulates Cancer Stem-Like Cell Properties in KRAS-Driven Lung Adenocarcinoma.
Li Y; Zhang X; Zhu S; Dejene EA; Peng W; Sepulveda A; Seto E
Cancer Res; 2020 Aug; 80(16):3265-3278. PubMed ID: 32540961
[TBL] [Abstract][Full Text] [Related]
18. Loss of dystrophin expression in skeletal muscle is associated with senescence of macrophages and endothelial cells.
Young LV; Morrison W; Campbell C; Moore EC; Arsenault MG; Dial AG; Ng S; Bellissimo CA; Perry CGR; Ljubicic V; Johnston AP
Am J Physiol Cell Physiol; 2021 Jul; 321(1):C94-C103. PubMed ID: 33979211
[TBL] [Abstract][Full Text] [Related]
19. Senescent cells in cancer therapy: why and how to remove them.
Zhang JW; Zhang D; Yu BP
Cancer Lett; 2021 Nov; 520():68-79. PubMed ID: 34237406
[TBL] [Abstract][Full Text] [Related]
20. Pro- and anti-tumorigenic functions of the senescence-associated secretory phenotype.
Lau L; David G
Expert Opin Ther Targets; 2019 Dec; 23(12):1041-1051. PubMed ID: 30616404
[No Abstract] [Full Text] [Related]
[Next] [New Search]
